Cervical Pathology Following HPV Vaccination in Greece: A 10-year HeCPA Observational Cohort Study

Background: In Greece the population-level impact of HPV vaccination is unknown due to lack of official registries. This study presents in a pragmatic frame the comparison of cervical pathology data between HPV-vaccinated and unvaccinated women referred for colposcopy. Patients and Methods: This is...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:In vivo (Athens) 2020-05, Vol.34 (3), p.1445-1449
Hauptverfasser: Paraskevaidis, Evangelos, Athanasiou, Antonios, Paraskevaidi, Maria, Bilirakis, Evripidis, Galazios, Georgios, Kontomanolis, Emmanuel, Dinas, Konstantinos, Loufopoulos, Aristotelis, Nasioutziki, Maria, Kalogiannidis, Ioannis, Athanasiadis, Apostolos, Papanikolaou, Alexios, Vatopoulou, Anastasia, Grimbizis, Gregorios, Tsolakidis, Dimitrios, Daponte, Alexandros, Valasoulis, George, Gritzeli, Stella, Michail, Georgios, Adonakis, Georgios, Paschopoulos, Minas, Tsonis, Orestis, Anaforidou, Maria-Eugenia, Batistatou, Anna, Kyrgiou, Maria
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background: In Greece the population-level impact of HPV vaccination is unknown due to lack of official registries. This study presents in a pragmatic frame the comparison of cervical pathology data between HPV-vaccinated and unvaccinated women referred for colposcopy. Patients and Methods: This is an observational prospective cohort study performed in 7 academic Obstetrics and Gynaecology Departments across Greece between 2009-2019. Cases were women that had completed HPV vaccination before coitarche and were referred for colposcopy due to abnormal cytology. For each vaccinated woman an unvaccinated matched control was selected. Results: A total of 849 women who had been vaccinated before coitarche and 849 unvaccinated controls were recruited. The combination of cytological, colposcopic and molecular findings necessitated treatment in only a single case among vaccinated (0.1%) and in 8.4% among unvaccinated. Conclusion: HPV vaccination at a proper age can markedly reduce development of severe cervical precancers and consequently the need for treatment, as well as their long-term related obstetrical morbidity.
ISSN:0258-851X
1791-7549
DOI:10.21873/invivo.11927